Ikarian Capital, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$553,000
-29.0%
221,252
+5.8%
0.07%
-37.1%
Q4 2021$779,000
-37.5%
209,082
-32.8%
0.12%
+31.8%
Q3 2021$1,247,000
-32.5%
311,041
-25.1%
0.09%
-40.9%
Q2 2021$1,847,000
-51.4%
415,0000.0%0.15%
+16.4%
Q1 2021$3,797,000
-9.8%
415,0000.0%0.13%
-31.2%
Q4 2020$4,208,000
+139.2%
415,0000.0%0.19%
+46.5%
Q3 2020$1,759,000415,0000.13%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders